Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence

Sabsabi S, Mikhael E, Jalkh G, Macaron G, Rensel M

Patient Preference and Adherence 2022, 16:1307-1319

Published Date: 24 May 2022